|
|
The Construction of Recombinant Adenovirus Delivering Chimeric Neurturin and Activity Assay in vitro |
WANG Wen-ju,SUN Mao-sheng,YAN Min,LI Hong-jun |
Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming 650118, China |
|
|
Abstract Neurturin is a member of neurotrophic family, and the gene engineering product of the Neurturin can promote the survival of the dopaminergic neurons, which is a new approach to the therapy of Parkinson’s disease. However, a few researches have indicated that the wild type of Neurturin cannot be processed and secreted into the medium. Therefore, the study intends to rebuilt the gene of wtNeurturin and replaced the signal peptide of wtNeurturin by the counterpart of NGF. The hybrid Neurturin was inserted into the genome of adenovirus and packaged in AD-293 cells. The chimeric Neurturin could be expressed in cytoplasm of vero cells and be processed and secreted, which was detected by immunofluorescence and Western blotting. Finally, the culture of dorsal root ganglia of chick embryo test had indicated that Neurturin expressed by chimeric gene had good biological activity.
|
Received: 05 May 2010
Published: 25 August 2010
|
|
|
[1] Gasmi M, Herzog C D, Brandon E P, et al. Striatal delivery of neurturin by CERE120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson’s disease. Mol Ther,2007, 15(1):6268.
[2] Toulouse A, Sullivan A M. Progress in Parkinson’s diseasewhere do we stand? Prog Neurobiol,2008, 85(4):376392.
[3] Cheng S D, Zhou H Y. Yesterday, Today and Tomorrow of Parkinson’s Disease. Journal of Chinese Neurology, 2006, 39(6):361363.
[4] Bjorklund T, Kordower J H. Gene therapy for Parkinson’s disease. Mov Disord, 2010, 25(Suppl 1):S161S173.
[5] Li H, Ma Y, Su T, et al Expression, purification, and characterization of recombinant human neurturin secreted from the yeast Pichia pastoris. Protein Expr Purif, 2003, 30(1):1117.
[6] Kordower J H, Herzog C D, Dass B, et al. Delivery of neurturin by AAV2 (CERE120)mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTPtreated monkeys. Ann Neurol, 2006, 60(6):706715.
[7] Kordower J H, Emborg M E, Bloch J, et al. Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson’s Disease. Science, 2000,290(27):767773.
[8] Hoane M R, Gulwadi A G, Morrison S, et al. Differential in vivo effects of neurturin and glial celllinederived neurotrophic factor. Exp Neurol, 1999, 160(1):235243.
[9] Georgievska B, Kirik D, Bjrklund A. Overexpression of glial cell linederived neurotrophic factor using a lentiviral vector induces time and dosedependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J Neurosci, 2004, 24(29):64376445.
[10] FjordLarsen L, Johansen J L, Kusk P, et al. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Exp Neurol, 2005, 195(1):4960.
[11] Suter U,Heymach J V,Shooter E M. Two conserved domain in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NFG. EMBO J, 1991,10(9):23952400. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|